• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    145.30 Down 2.11(1.43%) Jan 23, 4:00PM EST
    |After Hours : 145.35 Up 0.05 (0.03%) Jan 23, 7:05PM EST
    Add to Portfolio
    Prev Close:147.41
    Open:147.39
    Bid:137.02 x 1000
    Ask:N/A
    1y Target Est:129.53
    Beta:1.35
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:144.81 - 148.96
    52wk Range:84.63 - 149.02
    Volume:396,740
    Avg Vol (3m):632,289
    Market Cap:6.90B
    P/E (ttm):40.98
    EPS (ttm):3.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for UTHR

    Comparison

    Symbol% ChgMkt Cap
    UTHRDown 1.43%6.90B
    GILDUp 0.38%159.22B
    PFEDown 1.10%204.46B

    Key Statistics

    Forward P/E (1 yr):14.71
    P/S (ttm):5.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :6.87
    Quarterly EPS Est (Dec-14) :2.09
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.78

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback